Markets

Commodities

Currencies

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

The Blueprint for Better Lung Cancer Screening

The Quest to Repair What Multiple Sclerosis Takes Away

loader